Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

DAU Arxiu Digital de la Universitat Ramon Llull
Publication Artículo científico (JournalArticle)

Remission of obesity and insulin resistance is not sufficient to restore mitochondrial homeostasis in visceral adipose tissue

  • Gonzalez-Franquesa, Alba
  • Gama Pérez, Pau
  • Kulis, Marta
  • Szczepanowska, Karolina
  • Dahdah, Norma
  • Moreno-Gomez, Sonia
  • Latorre-Pellicer, Ana
  • Fernández-Ruiz, Rebeca
  • Aguilar-Mogas, Antoni
  • Hoffman, Anne
  • Monelli, Erika
  • Samino, Sara
  • Miró-Blanch, Joan
  • Oemer, Gregor
  • Duran, Xavier
  • Sanchez-Rebordelo, Estrella
  • Schneeberger, Marc
  • Obach, Merce
  • Montane, Joel
  • Castellano, Giancarlo
  • Chapaprieta, Vicente
  • Sun, Wenfei
  • Navarro, Lourdes
  • Prieto, Ignacio
  • Castaño, Carlos
  • Novials, Anna
  • Gomis, Ramon
  • Monsalve, Maria
  • Claret, Marc
  • Graupera, Mariona
  • Soria, Guadalupe
  • Wolfrum, Christian
  • Vendrell, Joan
  • Fernández-Veledo, Sonia
  • Enríquez, José Antonio
  • Carracedo, Angel
  • Perales , José Carlos
  • Nogueiras, Ruben
  • Herrero, Laura
  • Trifunovic, Aleksandra
  • Keller, Markus A.
  • Yanes, Oscar
  • Sales-Pardo, Marta
  • Guimerà, Roger
  • Blüher, Matthias
  • Martín-Subero, José Ignacio
  • Garcia-Roves, Pablo M.
Metabolic plasticity is the ability of a biological system to adapt its metabolic phenotype to different environmental stressors. We used a whole-body and tissue-specific phenotypic, functional, proteomic, metabolomic and transcriptomic approach to systematically assess metabolic plasticity in diet-induced obese mice after a combined nutritional and exercise intervention. Although most obesity and overnutrition-related pathological features were successfully reverted, we observed a high degree of metabolic dysfunction in visceral white adipose tissue, characterized by abnormal mitochondrial morphology and functionality. Despite two sequential therapeutic interventions and an apparent global healthy phenotype, obesity triggered a cascade of events in visceral adipose tissue progressing from mitochondrial metabolic and proteostatic alterations to widespread cellular stress, which compromises its biosynthetic and recycling capacity. In humans, weight loss after bariatric surgery showed a transcriptional signature in visceral adipose tissue similar to our mouse model of obesity reversion. Overall, our data indicate that obesity prompts a lasting metabolic fingerprint that leads to a progressive breakdown of metabolic plasticity in visceral adipose tissue., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Remission of obesity and insulin resistance is not sufficient to restore mitochondrial homeostasis in visceral adipose tissue

  • Gonzalez-Franquesa, Alba
  • Gama Pérez, Pau
  • Kulis, Marta
  • Szczepanowska, Karolina
  • Dahdah, Norma
  • Moreno-Gomez, Sonia
  • Latorre-Pellicer, Ana
  • Fernández-Ruiz, Rebeca
  • Aguilar-Mogas, Antoni
  • Hoffman, Anne
  • Monelli, Erika
  • Samino, Sara
  • Miró-Blanch, Joan
  • Oemer, Gregor
  • Duran, Xavier
  • Sanchez-Rebordelo, Estrella
  • Schneeberger, Marc
  • Obach, Merce
  • Montane, Joel
  • Castellano, Giancarlo
  • Chapaprieta, Vicente
  • Sun, Wenfei
  • Navarro, Lourdes
  • Prieto, Ignacio
  • Castaño, Carlos
  • Novials, Anna
  • Gomis, Ramon
  • Monsalve, Maria
  • Claret, Marc
  • Graupera, Mariona
  • Soria, Guadalupe
  • Wolfrum, Christian
  • Vendrell, Joan
  • Fernández-Veledo, Sonia
  • Enríquez, José Antonio
  • Carracedo, Angel
  • Perales , José Carlos
  • Nogueiras, Ruben
  • Herrero, Laura
  • Trifunovic, Aleksandra
  • Keller, Markus A.
  • Yanes, Oscar
  • Sales-Pardo, Marta
  • Guimerà, Roger
  • Blüher, Matthias
  • Martín-Subero, José Ignacio
  • Garcia-Roves, Pablo M.
Metabolic plasticity is the ability of a biological system to adapt its metabolic phenotype to different environmental stressors. We used a whole-body and tissue-specific phenotypic, functional, proteomic, metabolomic and transcriptomic approach to systematically assess metabolic plasticity in diet-induced obese mice after a combined nutritional and exercise intervention. Although most obesity and overnutrition-related pathological features were successfully reverted, we observed a high degree of metabolic dysfunction in visceral white adipose tissue, characterized by abnormal mitochondrial morphology and functionality. Despite two sequential therapeutic interventions and an apparent global healthy phenotype, obesity triggered a cascade of events in visceral adipose tissue progressing from mitochondrial metabolic and proteostatic alterations to widespread cellular stress, which compromises its biosynthetic and recycling capacity. In humans, weight loss after bariatric surgery showed a transcriptional signature in visceral adipose tissue similar to our mouse model of obesity reversion. Overall, our data indicate that obesity prompts a lasting metabolic fingerprint that leads to a progressive breakdown of metabolic plasticity in visceral adipose tissue., info:eu-repo/semantics/publishedVersion
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

To be or not to be a fat burner, that is the question for cpt1c in cancer cells

  • Fadó, Rut|||0000-0002-3293-2342
  • Zagmutt, Sebastian|||0000-0001-6050-4452
  • Herrero, Laura|||0000-0003-4244-4673
  • Muley, Helena|||0000-0003-0979-4815
  • Rodríguez-Rodríguez, Rosalía
  • Bi, Huichang
  • Serra, Dolors|||0000-0002-4936-4206
  • Casals, Nuria|||0000-0002-6719-4300
There is an urgent need to identify reliable genetic biomarkers for accurate diagnosis, prognosis, and treatment of different tumor types. Described as a prognostic marker for many tumors is the neuronal protein carnitine palmitoyltransferase 1 C (CPT1C). Several studies report that CPT1C is involved in cancer cell adaptation to nutrient depletion and hypoxia. However, the molecular role played by CPT1C in cancer cells is controversial. Most published studies assume that, like canonical CPT1 isoforms, CPT1C is a mediator of fatty acid transport to mitochondria for beta-oxidation, despite the fact that CPT1C has inefficient catalytic activity and is located in the endoplasmic reticulum. In this review, we collate existing evidence on CPT1C in neurons, showing that CPT1C is a sensor of nutrients that interacts with and regulates other proteins involved in lipid metabolism and transport, lysosome motility, and the secretory pathway. We argue, therefore, that CPT1C expression in cancer cells is not a direct regulator of fat burn, but rather is a regulator of lipid metabolic reprograming and cell adaptation to environmental stressors. We also review the clinical relevance of CPT1C as a prognostic indicator and its contribution to tumor growth, cancer invasiveness, and cell senescence. This new and integrated vision of CPT1C function can help better understand the metabolic plasticity of cancer cells and improve the design of therapeutic strategies.